When predicting cognitive impairment across the entire cohort, CSF pT217/T217, CSF t-tau/Aβ40lumi, CSF p-tau/Aβ40lumi and amyloid PET were the strongest predictors, likely due to their robust ability to identify the presence of underlying Alzheimer’s disease pathophysiology. This evidence concerns the gene MAPT and Cognitive impairment.